Immunopharmacological studies of ribavirin, a broad-spectrum antiviral agent.
D000818:Animals; D003602:Cytotoxicity, Immunologic / Q000187:drug effects; D005260:Female; D006086:Graft vs Host Disease; D006968:Hypersensitivity, Delayed; D007113:Immunity, Innate / Q000187:drug effects; D066298:In Vitro Techniques; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology; D008213:Lymphocyte Activation / Q000187:drug effects; D017710:Lymphocyte Transfusion; D008214:Lymphocytes / Q000276:immunology*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D008815:Mice, Inbred Strains; D011552:Pseudomonas Infections / Q000276:immunology; D012254:Ribavirin / Q000494:pharmacology* / Q000633:toxicity; D012263:Ribonucleosides / Q000494:pharmacology*; D014184:Transplantation, Homologous
D012263:Ribonucleosides; D012254:Ribavirin